AirInSpace, a leading supplier of mobile devices that ‘catch and inactivate’ harmful and resistant biological particles from the air, announced today that data from a multi-year clinical study shows a significant reduction in aspergillosis infection rates in a standard hospital setting when using the Company’s patented PlasmairT2006 mobile unit with HEPA-MD™ technology. (PRWeb Jul 2, 2008) Read the full story at http://www.prweb.com/releases/airinspace/infection/prweb1071144.htm ...